Aspiriant LLC’s Deere & Co DE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$568K Buy
1,009
+2
+0.2% +$1.13K 0.02% 204
2025
Q4
$469K Buy
1,007
+1
+0.1% +$469 0.01% 222
2025
Q3
$460K Sell
1,006
-33
-3% -$16.3K 0.01% 207
2025
Q2
$528K Sell
1,039
-25
-2% -$12.2K 0.02% 189
2025
Q1
$499K Buy
1,064
+52
+5% +$24.3K 0.02% 190
2024
Q4
$429K Sell
1,012
-14
-1% -$5.9K 0.02% 202
2024
Q3
$428K Sell
1,026
-156
-13% -$58.8K 0.02% 200
2024
Q2
$442K Sell
1,182
-270
-19% -$105K 0.02% 196
2024
Q1
$597K Buy
1,452
+38
+3% +$14.6K 0.02% 180
2023
Q4
$566K Buy
1,414
+105
+8% +$39.6K 0.03% 182
2023
Q3
$494K Buy
1,309
+62
+5% +$25.6K 0.03% 180
2023
Q2
$505K Buy
1,247
+80
+7% +$30.6K 0.03% 178
2023
Q1
$482K Buy
1,167
+1
+0.1% +$414 0.03% 181
2022
Q4
$500K Buy
1,166
+91
+8% +$37K 0.03% 178
2022
Q3
$359K Sell
1,075
-56
-5% -$19.2K 0.02% 192
2022
Q2
$339K Sell
1,131
-11
-1% -$4.05K 0.02% 198
2022
Q1
$475K Buy
1,142
+158
+16% +$60.5K 0.03% 178
2021
Q4
$337K Buy
+984
New +$342K 0.02% 222

Other funds holding DE

Aspiriant LLC's DE Position: Q1 2026 in Review

Aspiriant LLC increased its Deere & Co (DE) stake by 0.2% in Q1 2026, buying an estimated $1.13K and bringing the position to 1,009 shares worth $568K. The position accounts for 0.02% of the portfolio, ranked #204.

Aspiriant LLC first reported a position in DE in Q4 2021 and has held it in 18 quarters since. The position peaked at $597K in Q1 2024. 2,579 funds tracked by Wall St. Rank hold DE as of Q1 2026.

  • Aspiriant LLC held 1,009 shares of Deere & Co worth $568K as of Q1 2026.
  • Aspiriant LLC bought 2 Deere & Co shares in Q1 2026, an estimated $1.13K.
  • Deere & Co made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #204 holding.
  • Aspiriant LLC first reported a position in Deere & Co in Q4 2021 and has held it in 18 quarters since.
  • Aspiriant LLC's Deere & Co position peaked at $597K in Q1 2024.
  • 2,579 funds tracked by Wall St. Rank held Deere & Co as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.